Company intelligence
biotalent.ai
Matching biotech talent and companies
About biotalent.ai
We’ve built an intelligence platform for the life sciences industry: a continuously updated database of companies, opportunities, and professionals, combined with models that understand how the industry is evolving. Our graph maps companies, teams, technologies, employees, and career paths, then uses that context to identify unusually strong matches between professionals and opportunities—putting data science behind recruiting to connect people with roles that genuinely fit their experience and career goals.
Verified activity
Signals from biotalent.ai
19 published signals
Research & Knowledge
biotalent.ai highlights that Sutro Biopharma is testing a preclinical PTK7-directed ADC called STRO-227, which carries two different cancer drugs on the same antibody.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studied Legend Biotech to find 498 mapped openings across U.S., Canada, Europe, and UK scope.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai reviewed the University of Chicago protein-engineering ecosystem spanning computational design, binder selection, structural biology, monobodies, and company translation.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studied AbCellera pay bands across antibody discovery, CMC, QC, MSAT, clinical supply, and pharmacology.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studied Evotec and found that Evotec lists 471 open roles across the U.S., Canada, Europe, plus the UK.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studies biotech companies at the team level to analyze technologies, products, workflows, programs, and scientific priorities.
Reported by Fyodor Minakov
Customers & Market
biotalent.ai studied Ireland's medicine supply base joining API chemistry, sterile filling, biologics, oral dose, testing, packaging, release, warehousing, and distribution in a compact national footprint.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studies biotech companies at the team level to analyze their technologies, products, workflows, programs, and scientific priorities.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studies biotech companies at the team level, analyzing their technologies, products, workflows, programs, and scientific priorities.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai followed 2,000+ PhD researchers across multiple scientific fields to trace how their work changed after graduation.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studies biotech companies at the team level to analyze their technologies, products, workflows, programs, and scientific priorities.
Reported by Fyodor Minakov
Capital & Finance
biotalent.ai studied Vaderis biotech company and raised $152M as HEROIC Phase 3 starts for engasertib in HHT.
Reported by Fyodor Minakov
Capital & Finance
biotalent.ai studied Remedium Bio and announced an initial close toward a planned $10M Series A for long-acting protein therapeutics.
Reported by Fyodor Minakov
Capital & Finance
biotalent.ai studied Infinimmune biotech company and raised $75M around IFX-101, IFX-201, patient-derived antibodies, GLIMPSE models, atopic dermatitis, and 2027 study plans.
Reported by Fyodor Minakov
Capital & Finance
biotalent.ai studied Epicrispr biotech company and raised $90M for EPI-321 in FSHD after Phase 1/2 enrollment, with more 2026 data expected.
Reported by Fyodor Minakov
Capital & Finance
biotalent.ai studied Aureka biotech company and raised US$100M, with nearly US$200M raised so far, aimed at biological foundation models plus Lab-in-Loop cycles.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studies biotech companies at the team level to analyze their technologies, products, workflows, programs, and scientific priorities.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studied Evo 1 and Evo 2 to generate bacteriophage genome candidates.
Reported by Fyodor Minakov
Research & Knowledge
biotalent.ai studies biotech companies at the team level to connect candidates with teams where their experience fits.
Reported by Fyodor Minakov